1 PANEL RAPID DRUG TEST
BUPRENORPHINE ( BUP )
25/Box

OneStep Buprenorphine ( BUP ) InstaTest , 25/BOX )
25/Box
FOR THE QUALITATIVE ASSESSMENT OF BUPRENORPHINE IN HUMAN URINE .
INTENDED USE
BUP RapiCard is an immunochromatography based one step in vitro test.
It is designed for qualitative determination of the major metabolite of buprenorphine, buprenorphine-3-β-d-glucoronide, in human urine specimens at cut-off level of 10 ng/ml.
This assay has not been evaluated in the point of care location and is for use by Healthcare Professionals only.
This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.